Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Joseph Miller

Emergency Medicine Detroit, MI Medical Doctor

NPI 1780893982 CMS profile 216637

2799 W Grand Blvd, Department Of Emergency Medicine, Detroit, MI 48202

Open in the dashboard

General payments

$202,471

169 records reported · program years 2019–2025

Research payments

$121,945

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$2,071,897 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Joseph Miller of Detroit, MI is reported in the CMS Open Payments database as having received $202,471 across 169 general payments and $121,945 in research payments paid to them. Separately, studies naming them as principal investigator received $2,071,897 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 99th percentile of Emergency Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $17,410 17
2024 General $33,091 38
2024 Research $121,945 1
2023 General $58,326 53
2022 General $37,707 23
2021 General $30,852 23
2020 General $19,804 13
2019 General $5,280 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Joseph Miller
  • Emergency Medicine median
  • Middle half of Emergency Medicine
  • National median

In program year 2025, general payments to Joseph Miller were reported at $17,410. Among 10,690 Emergency Medicine profiles paid that year, the median was $57 and the middle half received between $24 and $150.

Show as a table
Year Joseph Miller Emergency Medicine median Middle half National median
2019 $5,280 $51 $18–$128 $163
2020 $19,804 $29 $16–$99 $114
2021 $30,852 $40 $18–$124 $132
2022 $37,707 $49 $20–$134 $149
2023 $58,326 $51 $22–$142 $160
2024 $33,091 $52 $22–$150 $164
2025 $17,410 $57 $24–$150 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Gilead Sciences, Inc. $72,054 6 payments
  2. AstraZeneca Pharmaceuticals LP $56,177 80 payments
  3. Beckman Coulter, Inc. $22,069 21 payments
  4. Octapharma USA, Inc. $19,696 23 payments
  5. BioXcel Therapeutics, Inc. $15,339 28 payments
  6. Siemens Medical Solutions USA, Inc. $11,850 4 payments
  7. Quidel Corporation $3,483 3 payments
  8. Kowa Pharmaceuticals America, Inc. $894 1 payment
  9. Abbott Laboratories $600 1 payment
  10. Ceribell, Inc. $238 1 payment
  11. Other $72 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $107,307 23 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $64,150 32 payments
  3. Honoraria $15,995 5 payments
  4. Travel and Lodging $9,059 54 payments
  5. Food and Beverage $4,400 54 payments
  6. Compensation for serving as faculty or as a speaker for a medical education program $1,560 1 payment
Products named General payments · program years 2019–2025
  1. ANDEXXA $28,054 37 payments
  2. LOKELMA $28,029 41 payments
  3. BALFAXAR $19,696 23 payments
  4. IGALMI $15,339 28 payments
  5. DXI 800 $1,560 1 payment
  6. Seglentis $894 1 payment
  7. DXH 900 Hematology System $872 4 payments
  8. I-STAT $600 1 payment
  9. ACCESS 2 $595 2 payments
  10. POCKET EEG DEVICE $238 1 payment
  11. Other $215 4 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Abbott Laboratories $121,945 1 payment

Billing to Medicare

Part B · data year 2024 · 11 billing codes

Paid by Medicare

$5,759

Medicare's payments for the services billed

Medicare patients

43

Average age 68

Services billed

56

22 women, 21 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 60%
Arthritis 60%
Heart failure 51%
Diabetes 47%
Ischemic heart disease 42%
Depression 35%
Atrial fibrillation 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

170 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Emergency Medicine in Michigan

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record